TELUS delivered solid results in Q3 2025, including growth in net income, EPS, and free cash flow. Strong performance in TELUS Health and stable TTech adjusted EBITDA contributed to the results. Total revenue remained flat due to lower equipment sales, but service revenue grew. The company raised its quarterly dividend and reaffirmed its annual guidance.
Net income rose 68% to $431 million, driven by a gain on debt repurchase.
Adjusted EPS decreased to $0.24, while reported EPS increased to $0.32.
Free cash flow grew 8% to $611 million, supporting a quarterly dividend increase.
TELUS Health revenue rose 18%, contributing to overall EBITDA growth.
TELUS reaffirmed its 2025 targets for Adjusted EBITDA, capital expenditures, and free cash flow, but expects TTech revenue to land at the lower end of its original guidance.